Login / Signup

Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.

Daniel L FadenFernando Concha-BenaventeAnish B ChakkaElizabeth L McMichaelUma ChandranMatthew J Ferris
Published in: Head & neck (2019)
Alterations in HLA-C may provide a mechanism of immune evasion through disruption of NK activation.
Keyphrases
  • combination therapy
  • metastatic colorectal cancer
  • open label
  • locally advanced
  • nk cells
  • wild type
  • randomized controlled trial
  • squamous cell carcinoma